ENZL vs. CNCR ETF Comparison
Comparison of iShares MSCI New Zealand Capped ETF (ENZL) to Loncar Cancer Immunotherapy ETF (CNCR)
ENZL
iShares MSCI New Zealand Capped ETF
ENZL Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI New Zealand IMI 25/50 Index. The fund generally invests at least 80% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index is a free-float adjusted market capitalization weighted index with a capping methodology applied to issuer weights so that no single issuer of a component exceeds 25% of the underlying index weight and all issuers with weight above 5% do not exceed 50% of the underlying index weight. It is non-diversified.
Grade (RS Rating)
Last Trade
$48.78
Average Daily Volume
18,040
3
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.95
Average Daily Volume
4,117
67
Performance
| Period | ENZL | CNCR |
|---|---|---|
| 30 Days | -0.95% | 3.21% |
| 60 Days | 8.52% | 9.36% |
| 90 Days | 7.11% | 12.83% |
| 12 Months | 12.35% | 39.07% |
0 Overlapping Holdings
| Symbol | Grade | Weight in ENZL | Weight in CNCR | Overlap |
|---|
ENZL Underweight 67 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| SMMT | D | -6.18% | |
| GERN | D | -3.67% | |
| ELVN | A | -2.94% | |
| IGMS | C | -2.34% | |
| NRIX | D | -2.31% | |
| FHTX | C | -2.18% | |
| ACRV | F | -1.99% | |
| RVMD | B | -1.94% | |
| TYRA | C | -1.85% | |
| ERAS | D | -1.81% | |
| BNTX | B | -1.79% | |
| REPL | C | -1.78% | |
| TSVT | C | -1.75% | |
| KYMR | D | -1.73% | |
| JANX | C | -1.72% | |
| AURA | C | -1.7% | |
| ACLX | C | -1.67% | |
| NUVL | B | -1.65% | |
| EXEL | B | -1.61% | |
| HCM | B | -1.6% | |
| REGN | D | -1.53% | |
| NUVB | F | -1.53% | |
| MRUS | D | -1.51% | |
| BPMC | F | -1.48% | |
| CGEM | F | -1.43% | |
| BCYC | D | -1.42% | |
| DAWN | D | -1.4% | |
| ITOS | F | -1.38% | |
| IMTX | F | -1.37% | |
| BMY | A | -1.36% | |
| MRK | F | -1.33% | |
| IMRX | D | -1.29% | |
| XNCR | D | -1.29% | |
| RLAY | F | -1.28% | |
| KURA | F | -1.25% | |
| STRO | F | -1.23% | |
| IPHA | F | -1.23% | |
| YMAB | C | -1.21% | |
| GLUE | F | -1.19% | |
| RCUS | D | -1.18% | |
| SNDX | F | -1.17% | |
| GMAB | F | -1.13% | |
| LEGN | F | -1.05% | |
| SDGR | F | -1.02% | |
| ACET | F | -0.98% | |
| IDYA | F | -0.97% | |
| LYEL | F | -0.96% | |
| IOVA | D | -0.95% | |
| RPTX | D | -0.93% | |
| PGEN | F | -0.93% | |
| SWTX | F | -0.92% | |
| ALLO | D | -0.91% | |
| RXRX | F | -0.91% | |
| AUTL | D | -0.9% | |
| BMEA | D | -0.83% | |
| ARVN | F | -0.78% | |
| KPTI | D | -0.76% | |
| IMCR | F | -0.73% | |
| FATE | F | -0.69% | |
| PRLD | F | -0.67% | |
| VOR | F | -0.54% | |
| CRBU | F | -0.52% | |
| MRSN | D | -0.52% | |
| GNLX | D | -0.49% | |
| ZNTL | F | -0.37% | |
| RAPT | F | -0.33% | |
| MGNX | F | -0.28% |
ENZL: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
